Safety and efficacy analysis of long-term follow up real-world data with ibrutinib monotherapy in 58 patients with CLL treated in a single-center in Greece.

Autor: Dimou, Maria1 (AUTHOR) msdimou@gmail.com, Iliakis, Theodoros1 (AUTHOR), Pardalis, Vasileios1 (AUTHOR), Bitsani, Catherin1 (AUTHOR), Vassilakopoulos, Theodoros P.2 (AUTHOR), Angelopoulou, Maria2 (AUTHOR), Tsaftaridis, Panayiotis2 (AUTHOR), Papaioannou, Paraskevi1 (AUTHOR), Koudouna, Aspasia1 (AUTHOR), Kalyva, Sotiria1 (AUTHOR), Kyrtsonis, Marie-Christine1 (AUTHOR), Panayiotidis, Panayiotis1 (AUTHOR)
Zdroj: Leukemia & Lymphoma. Dec2019, Vol. 60 Issue 12, p2939-2945. 7p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje